Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
This study has been completed.
Study NCT00016302 Information provided by National Cancer Institute (NCI)
First Received on May 6, 2001. Last Updated on January 15, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
prednisone
vincristine sulfate
daunorubicin hydrochloride
asparaginase
methotrexate
cyclophosphamide
cytarabine
mercaptopurine
leucovorin calcium
dexamethasone
doxorubicin hydrochloride
thioguanine
radiation therapy
nelarabine
pegaspargase
pharmacological study
laboratory biomarker analysis
Additional drug interventions recognized in this trial
6-Mercaptopurine
BB 1101
Daunorubicin
Dexamethasone 21-phosphate
Dexamethasone acetate
Doxorubicin
Leucovorin
Levoleucovorin
Vincristine
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Alkylating Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Antibiotics, Antineoplastic
Antidotes
Antiemetics
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Antiviral Agents
Autonomic Agents
Central Nervous System Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Gastrointestinal Agents
Glucocorticoids
Growth Substances
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Nucleic Acid Synthesis Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Protective Agents
Reproductive Control Agents
Therapeutic Uses
Tubulin Modulators
Vitamin B Complex
Vitamins
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
